Cartesian Therapeutics, Inc.
USD9.79
+0.15 (+1.61%)
CEO
Carsten Brunn
IPO Date
2016-06-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.65
Prev. Close
$9.64
Day Low
$9.29
Day High
$9.96
52W Low
$5.60
52W High
$15.57
Market Cap
$0.29B
Volume
0.12M
| -6.0 |
| 31 Dec 2023 | FY | 100.0% | -844.9% | 49.9% | -72.0% | -0.02 | 1.33 | -0.5 |
| 31 Dec 2022 | FY | 98.2% | 31.9% | 37.7% | 21.3% | 0.40 | 5.91 | 3.9 |
| 31 Dec 2021 | FY | 100.0% | -30.2% | -114.1% | -16.1% | 1.57 | 2.00 | -12.1 |
| 31 Dec 2020 | FY | 100.0% | -415.0% | 382.5% | -41.6% | -1.96 | 1.86 | -3.7 |
| 31 Dec 2019 | FY | 100.0% | -829.0% | -659.2% | -55.6% | 2.30 | 2.77 | -1.6 |
| 31 Dec 2018 | FY | 100.0% | -7235.4% | 1205.9% | -146.9% | -3.95 | 1.20 | -0.8 |
| 31 Dec 2017 | FY | 100.0% | -31556.0% | -126.1% | -64.6% | 0.41 | 8.99 | -2.6 |
| 31 Dec 2016 | FY | 100.0% | -448.0% | -65.9% | -40.5% | 0.22 | 6.33 | -4.1 |
| -0.5 |
| 30 Sept 2025 | Q3 | -2731.2% | -7942.9% | 100.2% | -9.6% | -0.35 | 10.67 | -1.9 |
| 30 Jun 2025 | Q2 | 100.0% | 5330.9% | -628.7% | 4.1% | -5.28 | 13.33 | 4.2 |
| 31 Mar 2025 | Q1 | 100.0% | -1610.0% | 81.3% | -4.3% | -0.65 | 12.34 | -4.8 |
| 31 Dec 2024 | Q4 | 100.0% | 1350.9% | 150.7% | -2.4% | -2.06 | 9.43 | -11.3 |
| 30 Sept 2024 | Q3 | 100.0% | -6248.8% | -3215.8% | -5.3% | 19.48 | 10.70 | -3.6 |
| 30 Jun 2024 | Q2 | 100.0% | 41.4% | -13.6% | 4.0% | -0.15 | 4.78 | 7.3 |
| 31 Mar 2024 | Q1 | 100.0% | -973.0% | 48.7% | -17.5% | -0.09 | 3.03 | -0.4 |
| 31 Dec 2023 | Q4 | 100.0% | -2149.3% | 40.4% | -58.2% | -0.02 | 1.33 | -0.1 |